期刊文献+

哈尔滨地区男男性行为人群HIV-1感染未治疗者耐药基因变异分析 被引量:3

Virus subtype and drug resistance mutations among HIV-1 infected men who have sex with men in Harbin
原文传递
导出
摘要 目的了解2016年至2017年哈尔滨地区男男性行为人群(men who have sex with men,MSM)流行的人类免疫缺陷病毒1型(human immunodeficiency virus type 1,HIV-1)的亚型分布及原发耐药流行特点。方法收集哈尔滨市传染病院和哈尔滨医科大学附属第四医院60的新诊断的MSM途径HIV-1感染者未经抗逆转录病毒治疗(antiretroviral therapy,ART)的外周血样本,提取血浆中RNA,逆转录PCR和巢式PCR扩增HIV-1的gag、pol、int片段并纯化和测序。应用Mega 6.0软件构建系统进化树并分析病毒亚型。利用美国斯坦福大学HIV耐药检测系统分析耐药突变的种类和频率。结果成功获得50条gag基因序列、56条pol基因序列和44条int基因序列。亚型分析结果显示:CRF01_AE、CRF07_BC、B亚型和独特重组型(unique recombinant form,URF)分别占比为59.7%(34/57)、26.3%(15/57)、3.5%(2/57)和10.5%(6/57)。本研究共发现7份(12.5%)样本存在耐药突变,其中针对非核苷类逆转录抑制剂的耐药位点V179D/E/T频率最高为8.75%(5/56),此外还发现蛋白酶抑制剂耐药位点Q58E(1/56)和M46I(1/56)突变。未发现针对核苷类逆转录酶抑制剂和整合酶抑制剂的耐药突变位点。结论哈尔滨地区部分新诊断的MSM途径HIV-1感染者中以CRF01_AE亚型比例最多,其次为CRF07_BC和CRF01_AE与其他亚型重组株,耐药株所占比例较高,未发现整合酶抑制剂耐药突变。 Objective To investigate the distribution of subtypes of human immunodeficiency virus type 1(HIV-1)epidemic strains and the prevalence of primary drug resistance in the HIV infected individuals among men who have sex with men(MSM)population in Harbin from 2016 to 2017.Methods Peripheral blood samples with the antiretroviral therapy(ART)-na?ve were collected from 60 newly diagnosed HIV-1 infected individuals in Harbin Infectious Diseases Hospital and the Fourth Affiliated Hospital of Harbin Medical University.RNA was extracted from the plasma.HIV-1 gag,pol,and int gene fragments were amplified by reverse transcription PCR and nested PCR,purified,and sequenced.Phylogenetic tree and subtype analysis were performed using Mega 6.0 software.The type and frequency of drug resistance mutations were analyzed using the Stanford HIV Drug Resistance Database.Results 50 gag gene sequences,56 pol gene sequences,and 44 int gene sequences were successfully amplified.The subtype analysis showed that CRF01_AE,CRF07_BC,B subtypes,and unique recombinant forms(URF)accounted for 59.7%(34/57),26.3%(15/57),3.5%(2/57),and 10.5%(6/57),respectively.The drug resistance mutations were found in total of 7 samples(12.5%),among them the highest frequency of V179D/E/T was 8.75%(5/56)for non-nucleoside reverse transcription inhibitors.In addition,Q58E(1/56)and M46I(1/56)mutations which were resistance to protease inhibitors were also found.No resistance mutation sites to nucleoside reverse transcriptase inhibitors and integrase inhibitors were found.Conclusions Among the newly diagnosed HIV-1 infected individuals via MSM transmission route,the proportion of CRF01_AE subtypes is the highest,followed by CRF07_BC and other URF recombinant with CRF01_AE.The proportion of drug-resistant strains is higher and no drug resistance(DR)mutations to the integrase inhibitors was found.
作者 魏相辉 张雪莹 杨阳 王欣欣 赵一霖 王丽 凌虹 庄敏 Wei Xianghui;Zhang Xueying;Yang Yang;Wang Xinxin;Zhao Yilin;Wang Li;Ling Hong;Zhuang Min(Department of Microbiology,Harbin Medical University,Wu Lien-Teh Institute,Heilongjiang Provincial Key Laboratory of Infection and Immunity,Key Laboratory of Pathogen Biology in Heilongjiang Provincial Education Institute,Harbin 150081,China;Department of Infectious Diseases,Heilongjiang Provincial Hospital,Harbin 150036,China)
出处 《国际免疫学杂志》 CAS 2019年第3期241-245,共5页 International Journal of Immunology
基金 国家自然科学基金(81871654) 科技部十三五重大专项(2018ZXl0731101-002-004).
关键词 男男性行为者 人类免疫缺陷病毒 病毒亚型 耐药突变 Men who have sex with men Human immunodeficiency virus Virus subtype Drug resistance mutation
  • 相关文献

参考文献4

二级参考文献38

  • 1潘启超,薛以乐,康来仪,钟平,郑晓虹,林庆能,潘孝彰,金子辰,张玮,沈方伟,方蕙,宁镇,陈安琪,徐明珠,高咸明,庄鸣华,袁政安.上海市艾滋病感染者和病人中蛋白酶抑制剂耐药基因型的研究[J].上海预防医学,2004,16(7):311-313. 被引量:8
  • 2Maria Au,Jessica Haberer.Overview of HIV drug resistance and its implications for China[J].Chinese Medical Journal,2006(23):1999-2004. 被引量:15
  • 3薛以乐,宫菊丽,郑晓虹,盖晶,张玮,宁镇,庄鸣华,潘启超,卢伟,钟平,康来仪.上海市常住人口HIV-1感染者基因亚型和耐药性突变横断面研究[J].诊断学理论与实践,2007,6(3):203-209. 被引量:27
  • 4Chiu TK, Davies DR. Structure and function of HIV -I integrase[J]. CUlT Top Med Chern, 2004 ,4(9) :965-977.
  • 5Semenova EA, Marchand C, Pommier Y. HIV-l integrase inhihi- tors: update and perspectives[J]. Adv Phannacol, 2008, 56 : 199-228.
  • 6Markowitz M, Morales-RamirezJO, Nguyen BY, et al. Antiretro?viral activity, pharmacokinetics, and tolerability of MK.Q518, a novel inhibitor of HIV -1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-l-infected individuals[J].J Acquir Immune Defic Syndr, 2006,43(5) :509-515.
  • 7LennoxJL, Dejesus E, Lazzarin A, et al. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-l infection: a multicentre, double-blind randomised controlled trial[J]. Lancet, 2009,374 ( 9692) : 796 -806.
  • 8MouscadetJF, Delelis 0, Marcelin AG, et al. Resistance to HIV- 1 integrase inhibitors: A structural perspective[J]. Drug Resist Updat , 2010,13 (4-5) : 139-150.
  • 9GatellJM. The use of integrase inhibitors in treatment-experienced patients[J]. EurJ Med Res, 2009,14(SuppI3) :30-35.
  • 10Mansky LM. Retrovirus mutation rates and their role in genetic variation[J].J Gen Virol, 1998,79(Pt 6) :1337-1345.

共引文献470

同被引文献33

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部